PMCTPharmaCountry
    Home

Regulatory Updates

FDA, EMA, TGA and global regulatory developments

#Oxford Pharm ×

UPDATED
Regulatory Updates
Sep 9, 2026•1 min read
FDA Approves Oxford Pharm Generic Simvastatin Tablets (ANDA078735)
FDA has approved Oxford Pharm's abbreviated new drug application for generic simvastatin tablets in five strengths, all prescription oral products.